Evergreen Nephrology Names Craig Goguen Chief Executive Officer

2023-07-11

高管变更

Goguen is a seasoned healthcare executive and former CEO of multiple companies

NASHVILLE, Tenn., July 11, 2023 /PRNewswire/ -- Evergreen Nephrology is announcing the appointment of Craig Goguen as Chief Executive Officer, effective immediately.

Craig Goguen joins Evergreen Nephrology as new CEO

Tweet this

Evergreen Nephrology Names Craig Goguen Chief Executive Officer

Preview

来源: PRNewswire

Craig Goguen joins Evergreen Nephrology as new CEO

Goguen joins Evergreen with deep experience leading multi-state healthcare service businesses, including 15 years in the kidney care space. Prior to Evergreen, he served as CEO of Emerus Holdings, CEO of DSI Renal, and COO of Odyssey Healthcare. His expertise in building and developing leadership teams, coupled with his passion for providing world-class care to those who need it most, will be instrumental in driving Evergreen's initiative to support the millions who live with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) in the US.

"I could not be more excited about the future of Evergreen and the opportunity to work with Craig. He brings a wealth of leadership experience with a passion for creating servant-oriented cultures and providing the resources to help frontline clinicians serve patients," said Adam Boehler, Chairman of Evergreen Nephrology.

"I am honored to join Evergreen's mission to empower nephrologists to redefine the standard of care," says Goguen. "The current 'fee-for-service' healthcare system is broken. It has all the wrong incentives and is focused on providing more and more services without always improving quality or total cost-of-care. Evergreen's care model is flipping that script, allowing us to better care for this high-acuity patient population in collaboration with our physician partners. I am thrilled to be a part of this ground-breaking work."

Evergreen is creating a reimagined kidney-care experience for people living with kidney disease by offering clinical, technical, and financial support through long-term partnerships with more than 700 nephrology partners in 17 states. These partnerships provide patients living with CKD and ESKD personalized care that meets them where they are in their kidney-care journey with the goal of delaying disease progression, increasing transplants, decreasing unnecessary hospitalizations, shifting care to the home, and improving quality of life.

Current acting CEO, Scott Lloyd, is taking role of Chief Development and Strategy Officer, leading Evergreen's growth and partnerships initiatives. "I look forward to continuing to expand Evergreen's impact alongside Craig," said Lloyd. "Working closely with our nephrology partners, we are already making a lasting impact for those who matter most – people living with kidney disease."

About Evergreen Nephrology

Evergreen Nephrology is taking a patient-centric approach to kidney care. In collaboration with our nephrologist and payor partners, Evergreen focuses on fostering a holistic-care experience for individuals living with chronic kidney disease by empowering them through shared decision making to take an active role in their own health. With over 700 provider partners across 17 states, Evergreen is making personalized, physician-led care the national standard for kidney care.

For more information on Evergreen:

www.EvergreenNephrology.com

SOURCE Evergreen Nephrology

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构